Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Pharmacogenomics of HIV therapy: Summary of a workshop sponsored by the National Institute of allergy and infectious diseases
HIV Clinical Trials, Volume 12, No. 5, Year 2011
Notification
URL copied to clipboard!
Description
Approximately 1 million people in the United States and over 30 million worldwide are living with human immunodefi ciency virus type 1 (HIV-1). While mortality from untreated infection approaches 100%, survival improves markedly with use of contemporary antiretroviral therapies (ART). In the United States, 25 drugs are approved for treating HIV-1, and increasing numbers are available in resource-limited countries. Safe and effective ART is a cornerstone in the global struggle against the acquired immunodefi ciency syndrome. Variable responses to ART are due at least in part to human genetic variants that affect drug metabolism, drug disposition, and off-site drug targets. Defi ning effects of human genetic variants on HIV treatment toxicity, effi cacy, and pharmacokinetics has far-reaching implications. In 2010, the National Institute of Allergy and Infectious Diseases sponsored a workshopentitled,Pharmacogenomics A Path Towards Personalized HIV Care. This article summarizes workshop objectives, presentations, discussions, and recommendations derived from this meeting. © 2011 Thomas Land Publishers, Inc.
Authors & Co-Authors
Haas, David William
United States, Nashville
Vanderbilt University Medical Center
Kuritzkes, Daniel R.D.
United States, Boston
Brigham and Women's Hospital
Ritchie, Marylyn D.
United States, Nashville
Vanderbilt University Medical Center
Amur, Shashi
United States, Silver Spring
Food and Drug Administration
Gage, Brian
United States, St. Louis
Washington University in St. Louis
Maartens, Gary Tuberculosis
South Africa, Cape Town
University of Cape Town
Masys, Daniel R.
United States, Nashville
Vanderbilt University Medical Center
Fellay, Jacques
Switzerland, Lausanne
Université de Lausanne Unil
Phillips, Elizabeth Jane
Australia, Perth
Murdoch University
Ribaudo, Heather J.
United States, Boston
Harvard T.h. Chan School of Public Health
Freedberg, Kenneth A.
United States, Boston
Massachusetts General Hospital
Petropoulos, Christos J.
United States, San Francisco
Monogram Biosciences
Manolio, Teri A.
United States, Bethesda
National Human Genome Research Institute Nhgri
Gulick, Roy M.
United States, New York
Weill Cornell Medicine
Haubrich, Richard H.
United States, La Jolla
University of California, San Diego
Kim, Peter S.
United States, Bethesda
National Institute of Allergy and Infectious Diseases Niaid
Dehlinger, Marjorie
United States, Bethesda
National Institute of Allergy and Infectious Diseases Niaid
Abebe, Rahel
United States, Bethesda
Henry Jackson Foundation Medical Research International
Telenti, Amalio
Switzerland, Lausanne
Université de Lausanne Unil
Statistics
Citations: 19
Authors: 19
Affiliations: 15
Identifiers
Doi:
10.1310/hct1205-277
ISSN:
15284336
e-ISSN:
19455771
Research Areas
Genetics And Genomics
Infectious Diseases